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Lack of polymyxin resistance among carbapenemase-
producing Enterobacteriaceae in a university hospital
in China
Sir,
We read with interest two recent articles in the present
journal focusing on escalation of carbapenamase-produc-
ing Enterobacteriaceae in the hospital environment, one
from the Zhejing Province, China [1], and another from
Northern Italy [2]. Multidrug resistance is increasingly
reported in clinical enterobacterial isolates in China. Not
only resistance to carbapenems is on the rise, but in
addition co-resistance to other clinically-relevant antibi-
otics such as fluoroquinolones, aminoglycosides and fos-
fomycin is increasingly observed. Polymyxins are
therefore considered as last resort antibiotics for treating
infections due to multidrug-resistant Gram negatives.
Recently, plasmid-mediated colistin resistance (MCR-1)
was reported in enterobacterial from animals, food and
patients from China [3]. Beyond China, the spread of the
mcr-1 gene has been now reported worldwide in many
enterobacterial species [4]. In addition, one of the major
concern is the spread of carbapenem- and polymyxin-
resistant nosocomial Klebsiella pneumoniae isolates as
observed in Italy [5] and more recently in France [6].
High plasmid-mediated mcr-1 carriage rate has been
observed in E. coli collected from raw meat (15%) and
animals (21%) in China, but not from inpatients (1%) [3].
Recently, a variant of MCR-1, namely MCR-2, has been
reported from Belgium [7].
Taking into account the wide spread MCR-1-produc-
ing strains in China and elsewhere, the diversity of gen-
etic structures associated to the mcr-1 gene identified so
far, and the diversity of the clonal backgrounds of the
strains harboring that gene, it is likely that its spread
does not correspond to a recent event in China.
We have performed a retrospective study to evaluate
the occurrence of polymyxin resistance and of the
MCR-1 determinant among carbapenemase-producing
Enterobacteriaceae isolates, including 112 K. pneumoniae,
15 Escherichia coli, 15 Citrobacter freundii, 12 Enterobacter
aerogenes, 3 Klebsiella oxytoca, 2 Citrobacter farmeri, a
single Enterobacter cloacae and a single Citrobacter braa-
kii. Those clinical isolates have been recovered during
the 2006–2011 period at the Huashan Hospital of Fudan
University, Shanghai. Ninety-four were from sputum, 43
from urine, 6 from drainage, 5 from blood, 3 from cere-
brospinal fluid and 10 from other samples.
Carbapenemase activity was assessed using the Rapidec
Carba NP test (bioMerieux, La Balme-les-Grottes, France)
[8]. Carbapenemase genes were searched as previously
described [7]. All isolates were screened for polymyxin
resistance by using the recently-developed Rapid
Polymyxin NP test [9]. MICs of colistin and polymyxin B
were determined by broth microdilution method as rec-
ommended by CLSI [10]. All polymyxin-resistant isolates
were screened for the mcr-1 and mcr-2 genes by using
PCR with primers mcr-all-F (50-TATCGCTATGTGCTAAAG-
30) and mcr-all-R (50-TCTTGGTATTTGGCGGTA-30). All of
161 isolates were tested positive for the Rapidec Carba
NP test. Further PCR and sequencing showed that all
strains were positive for blaKPC-2. No polymyxin-resistant
isolate was detected using the Rapid Polymyxin NP test,
and further determination of MICs of colistin and poly-
myxin B confirmed that all isolates were susceptible to
polymyxins. Accordingly, all isolates tested negative for
the mcr-1 and mcr-2 genes.
This study revealed the absence of polymyxin-resist-
ant isolate in our collection of carbapenemase-producing
enterobacterial isolates. Combining with results obtained
through other Chinese studies [4,6,8], our data suggest
that polymyxin resistance rates may be much lower than
expected in Chinese hospitals. However, surveillance of
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polymyxin resistance shall be implemented on a regular
basis to monitor its potential emergence in China.
To conclude, polymyxins might still constitute clinic-
ally-relevant options for treating infections caused by
carbapenemase-producing Enterobacteriaceae in China.
However, the use of polymyxins for humans is still not
approved in China, considering its significant toxicity.
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